Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_provenance.
- NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_assertion description "[Antagonists of the effect of lung cancer-derived galectin-1 on DCs and anti-HB-EGF blocking antibodies could, therefore, have therapeutic potential as antitumor agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_provenance.
- NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_assertion evidence source_evidence_literature NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_provenance.
- NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_assertion SIO_000772 22291012 NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_provenance.
- NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_assertion wasDerivedFrom befree-20150227 NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_provenance.
- NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_assertion wasGeneratedBy ECO_0000203 NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_provenance.
- befree-20150227 importedOn "2015-02-27" NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_provenance.